title: Neuropeptide RFRP inhibits the pacemaker activity of terminal nerve GnRH neurons.
abstract: The terminal nerve gonadotropin-releasing hormone (TN-GnRH) neurons show spontaneous pacemaker activity whose firing frequency is suggested to regulate the release of GnRH peptides and control motivation for reproductive behaviors. Previous studies of the electrophysiological properties of TN-GnRH neurons reported excitatory modulation of pacemaker activity by auto/paracrine and synaptic modulations, but inhibition of pacemaker activity has not been reported to date. Our recent study suggests that neuropeptide FF, a type of Arg-Phe-amide (RFamide) peptide expressed in TN-GnRH neurons themselves, inhibits the pacemaker activity of TN-GnRH neurons in an auto- and paracrine manner. In the present study, we examined whether RFamide-related peptides (RFRPs), which are produced in the hypothalamus, modulate the pacemaker activity of TN-GnRH neurons as candidate inhibitory synaptic modulators. Bath application of RFRP2, among the three teleost RFRPs, decreased the frequency of firing of TN-GnRH neurons. This inhibition was diminished by RF9, a potent antagonist of GPR147/74, which are candidate RFRP receptors. RFRP2 changed the conductances for Na(+) and K(+). The reversal potential for RFRP2-induced current was altered by inhibitors of the transient receptor potential canonical (TRPC) channel (La(3+) and 2-aminoethoxydiphenyl borate) and by a less selective blocker of voltage-independent K(+) channels (Ba(2+)). By comparing the current-voltage relationship in artificial cerebrospinal fluid with that under each drug, the RFRP2-induced current was suggested to consist of TRPC channel-like current and voltage-independent K(+) current. Therefore, synaptic release of RFRP2 from hypothalamic neurons is suggested to inhibit the pacemaker activity of TN-GnRH neurons by closing TRPC channels and opening voltage-independent K(+) channels. This novel pathway may negatively regulate reproductive behaviors.
authors: Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
authors: Chie
authors: C
authors: Umatani
authors: Hideki
authors: H
authors: Abe
authors: Yoshitaka
authors: Y
authors: Oka
mesh_terms: D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001464:Barium / Q000494:pharmacology; D001683:Biological Clocks / Q000187:drug effects*; D001896:Boron Compounds / Q000494:pharmacology; D003391:Cranial Nerves / Q000166:cytology* / Q000378:metabolism / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism; D007811:Lanthanum / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009479:Neuropeptides / Q000494:pharmacology*; D010473:Perciformes; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013569:Synapses / Q000187:drug effects; D050052:TRPC Cation Channels / Q000037:antagonists & inhibitors
chemical_list: D001896:Boron Compounds; D009479:Neuropeptides; C416987:RFamide peptide; D050052:TRPC Cation Channels; D001464:Barium; D007987:Gonadotropin-Releasing Hormone; D007811:Lanthanum; D012964:Sodium; C109986:2-aminoethoxydiphenyl borate; D011188:Potassium
keywords: RFamide-related peptide; dwarf gourami; gonadotropin-releasing hormone; neuromodulation; peptide